ARMEN AVETISYAN: Open Payments
NPI 1972909406 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 21 payments from 9 companies in 2025. Trend: 2023 $179 · 2024 $31 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $85 |
| ABBVIE INC. | 4 | $65 |
| Verona Pharma, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Ardelyx, Inc. | 2 | $51 |
| Amgen Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| PFIZER INC. | 2 | $38 |
| Novo Nordisk Inc | 1 | $24 |
Products named: Ohtuvayre, BREZTRI, IBSRELA, LEQVIO, General - Pain Management, EMBLEM MRI S-ICD, QULIPTA, OTEZLA.
Industry payments across CA — which companies pay providers there.
